the Effect of the CALIGALOC Orthosis on Standing and Walking of Hemiparetic Patients With Ankle Varus

University Hospital, Lille

Status: Enrolling

Conditions: Hemiparesis; Varus Deformity of Equine Carpus

Treatments: Device: Caligaloc

Study type: Interventional

Funder types: Other

Identifiers

NCT03668561

2017-A02098-45 (Other Identifier)

2017_01

Details and patient eligibility

About

To assess the benefit of an anti-varus ankle foot orthosis (CALIGALOC, Bauerfeind) on gait and balance parameters in hemiparetic patients.

Enrollment: 30 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hemiparesis at > 3 months (whatever the etiology)
• varus or equinovarus foot disturbing the stance phase of gait
• Able to walk at least 10m, with or without assistive device

Exclusion criteria

• unable to walk 10m
• Botulinum toxin injection less than 3 months before inclusion
• history of neurological or locomotor pathology in addition to the etiology of hemiparesis
• Severe comprehension troubles
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Treatment (CALIGALOC)

Experimental group

Description:

Wearing of the Caligaloc orthosis

Treatment:

Device: Caligaloc